BioNTech
BNTX
BNTX
263 hedge funds and large institutions have $5B invested in BioNTech in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 75 increasing their positions, 99 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
24% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 99
31% less call options, than puts
Call options by funds: $295M | Put options by funds: $427M
51% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 49
Holders
263
Holding in Top 10
9
Calls
$295M
Puts
$427M
Top Buyers
| 1 | +$518M | |
| 2 | +$201M | |
| 3 | +$119M | |
| 4 |
Flossbach Von Storch
Cologne,
Germany
|
+$40.4M |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$32.8M |
Top Sellers
| 1 | -$79.8M | |
| 2 | -$44.5M | |
| 3 | -$41.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$35.7M |
| 5 |
Renaissance Technologies
New York
|
-$35.6M |